Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Community pharmacy

Pharmacy cut announcement delayed by government reshuffle

UK prime minister Theresa May

Source: Frederic Legrand - COMEO / Shutterstock

A spokesperson for the Department of Health says the pharmacy cuts announcement has been delayed as a result of changes within the health team following Theresa May’s takeover as UK prime minister

Final details about the £170m community pharmacy cuts, which were expected to be announced in July 2016, have been delayed, possibly until after October 2016, The Pharmaceutical Journal has learnt.

A spokesperson for the Department of Health (DH) says the delay to the announcement is a result of changeovers within the health team following Theresa May’s takeover as UK prime minister, and to allow the newly appointed pharmacy minister, David Mowat, time to review the policy and consultation.

“We will make an announcement in due course,” the DH says, adding that the hold-up could result in the cuts being delayed beyond October 2016, when they were due to be implemented, although no decisions have been made. “Everything’s up in the air while we’re getting ministers bedded in and having a look at this, so that will be a decision for new ministers to take,” the spokesperson says.

Former health minister Alistair Burt told the House of Commons in May 2016 that the DH would make a statement in July 2016 about the final details of the plans, in preparation for them to come into effect in October 2016.

The National Pharmacy Association (NPA), which is petitioning against the cuts, says: “Ministers and officials have been forced to think longer and harder about their plans as a result of the determined campaigning efforts of NPA members and many others in the sector, and patients too.”

Sandra Gidley, chair of the Royal Pharmaceutical Society’s English Pharmacy Board, says the RPS will be seeking an early meeting with Mowat and hopes he will “bring clarity” around the timing of the community pharmacy reforms, which are “currently causing great anxiety and concern in the sector”.

“It’s also important we continue to progress plans for pharmacists to have enhanced roles within community pharmacy, care homes, GP surgeries and urgent care to improve patient care.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201486

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • UK prime minister Theresa May

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.